Found: 32
Select item for more details and to access through your institution.
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 217, doi. 10.1007/s40121-021-00557-w
- By:
- Publication type:
- Article
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 4, p. 2399, doi. 10.1007/s40121-021-00506-7
- By:
- Publication type:
- Article
A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators.
- Published in:
- Infectious Diseases & Therapy, 2019, v. 8, n. 2, p. 185, doi. 10.1007/s40121-019-0243-4
- By:
- Publication type:
- Article
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 9, p. 1126, doi. 10.3390/antibiotics10091126
- By:
- Publication type:
- Article
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
- Published in:
- Brazilian Journal of Infectious Diseases, 2021, v. 25, n. 6, p. 1, doi. 10.1016/j.bjid.2021.101647
- By:
- Publication type:
- Article
The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal Cassette mec Linkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin-Resistant Staphylococcus aureus.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 11, p. 1523, doi. 10.1086/587907
- By:
- Publication type:
- Article
Identification of a 23S rRNA Gene Mutation in Clarithromycin-Resistant Helicobacter pylori.
- Published in:
- Helicobacter, 1996, v. 1, n. 4, p. 227, doi. 10.1111/j.1523-5378.1996.tb00043.x
- By:
- Publication type:
- Article
Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 549, doi. 10.1007/s40272-021-00468-w
- By:
- Publication type:
- Article
Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 605, doi. 10.2147/IDR.S342558
- By:
- Publication type:
- Article
New Antimicrobial Agents . . . but No Susceptibility Tests!
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 6, p. 754, doi. 10.1093/cid/ciw378
- By:
- Publication type:
- Article
Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20).
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 3, p. 1, doi. 10.1093/jacamr/dlac060
- By:
- Publication type:
- Article
Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 170, p. 1, doi. 10.1183/16000617.0117-2023
- By:
- Publication type:
- Article
Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012–2018.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12941-022-00504-8
- By:
- Publication type:
- Article
In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017).
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12941-020-00355-1
- By:
- Publication type:
- Article
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2672, doi. 10.1093/jac/dkad280
- By:
- Publication type:
- Article
The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 871, doi. 10.1093/jac/dkad049
- By:
- Publication type:
- Article
The primary pharmacology of ceftazidime/avibactam: resistance in vitro.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 569, doi. 10.1093/jac/dkac449
- By:
- Publication type:
- Article
The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodynamics (PK/PD).
- Published in:
- 2022
- By:
- Publication type:
- journal article
The primary pharmacology of ceftazidime/avibactam: in vitro translational biology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vitro activity of ceftazidime/avibactam and comparators against Gram-negative bacterial isolates collected from Latin American centres between 2015 and 2017.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013–17
- Published in:
- 2020
- By:
- Publication type:
- journal article
In vitro activity of ceftazidime/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015-17).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. 425, doi. 10.1093/jac/dky439
- By:
- Publication type:
- Article
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
- Published in:
- 2018
- By:
- Publication type:
- journal article
In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195281
- By:
- Publication type:
- Article